I. Etienne

Publication List Details

Period

1993 - 1993

Number

5

Co-Authors

Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment.

Leroy, A, Fillastre, J P, Borsa-Lebas, F, Etienne, I, Humbert, G

The pharmacokinetics of meropenem (ICI 194,660) and its open-ring metabolite (ICI 213,689) were studied in 6 healthy volunteers and 16 patients with moderate to severe renal impairment after a single...

Pharmacokinetics of sparfloxacin in patients with renal impairment.

Fillastre, J P, Montay, G, Bruno, R, Etienne, I, Dhib, M, Vivier, N, ...

The pharmacokinetics of sparfloxacin were studied in 14 renal failure patients (group I, 7 with creatinine clearance of > 10 to 30 ml/min; and group II, 7 with creatinine clearance of < or = 10...

Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment.

Leroy, A, Fillastre, J P, Borsa-Lebas, F, Etienne, I, Humbert, G

The pharmacokinetics of meropenem (ICI 194,660) and its open-ring metabolite (ICI 213,689) were studied in 6 healthy volunteers and 16 patients with moderate to severe renal impairment after a single...

Pharmacokinetics of sparfloxacin in patients with renal impairment.

Fillastre, J P, Montay, G, Bruno, R, Etienne, I, Dhib, M, Vivier, N, ...

The pharmacokinetics of sparfloxacin were studied in 14 renal failure patients (group I, 7 with creatinine clearance of > 10 to 30 ml/min; and group II, 7 with creatinine clearance of < or = 10...